SOL Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.62M Sell
36,507
-1,373
-4% -$174K 0.45% 63
2025
Q1
$4.85M Buy
37,880
+5,925
+19% +$758K 0.53% 52
2024
Q4
$4.23M Sell
31,955
-3,210
-9% -$424K 0.47% 60
2024
Q3
$5.12M Buy
35,165
+190
+0.5% +$27.7K 0.57% 48
2024
Q2
$4.8M Buy
34,975
+5,772
+20% +$792K 0.58% 49
2024
Q1
$4.01M Sell
29,203
-444
-1% -$60.9K 0.5% 53
2023
Q4
$4.03M Buy
29,647
+3,568
+14% +$485K 0.55% 55
2023
Q3
$3.19M Sell
26,079
-141
-0.5% -$17.2K 0.49% 63
2023
Q2
$3.33M Buy
26,220
+899
+4% +$114K 0.5% 58
2023
Q1
$3.27M Sell
25,321
-65
-0.3% -$8.4K 0.54% 56
2022
Q4
$3.33M Sell
25,386
-50
-0.2% -$6.57K 0.59% 48
2022
Q3
$2.98M Buy
25,436
+345
+1% +$40.4K 0.62% 43
2022
Q2
$2.95M Buy
25,091
+1,251
+5% +$147K 0.6% 46
2022
Q1
$3.11M Buy
23,840
+9,002
+61% +$1.17M 0.56% 46
2021
Q4
$2.27M Sell
14,838
-320
-2% -$48.8K 0.41% 73
2021
Q3
$2.45M Sell
15,158
-305
-2% -$49.3K 0.49% 57
2021
Q2
$2.53M Buy
15,463
+512
+3% +$83.8K 0.5% 57
2021
Q1
$2.25M Sell
14,951
-525
-3% -$79K 0.48% 59
2020
Q4
$2.34M Sell
15,476
-100
-0.6% -$15.1K 0.55% 54
2020
Q3
$2.11M Sell
15,576
-140
-0.9% -$19K 0.58% 52
2020
Q2
$2.15M Sell
15,716
-2,760
-15% -$377K 0.61% 45
2020
Q1
$1.99M Sell
18,476
-225
-1% -$24.2K 0.66% 40
2019
Q4
$2.25M Hold
18,701
0.57% 49
2019
Q3
$1.86M Hold
18,701
0.51% 57
2019
Q2
$2.04M Sell
18,701
-600
-3% -$65.5K 0.55% 53
2019
Q1
$2.16M Sell
19,301
-886
-4% -$99.1K 0.6% 49
2018
Q4
$1.95M Sell
20,187
-15
-0.1% -$1.45K 0.62% 45
2018
Q3
$2.46M Hold
20,202
0.67% 40
2018
Q2
$2.22M Buy
20,202
+200
+1% +$22K 0.63% 41
2018
Q1
$2.14M Sell
20,002
-20
-0.1% -$2.14K 0.61% 44
2017
Q4
$2.14M Hold
20,022
0.61% 45
2017
Q3
$2.23M Sell
20,022
-156
-0.8% -$17.3K 0.63% 43
2017
Q2
$2.09M Buy
20,178
+2,499
+14% +$258K 0.57% 45
2017
Q1
$1.73M Buy
17,679
+5,874
+50% +$574K 0.49% 54
2016
Q4
$1.04M Buy
+11,805
New +$1.04M 0.31% 80